Rocket Pharmaceuticals In...

NASDAQ: RCKT · Real-Time Price · USD
3.04
0.01 (0.33%)
At close: Aug 15, 2025, 3:59 PM
3.02
-0.68%
After-hours: Aug 15, 2025, 07:30 PM EDT

Rocket Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-257.3M -258.03M -258.75M -258.08M -253.26M -249.31M -245.59M -252.66M -248.51M -237.22M -221.86M -199.39M -191.75M -171.87M -169.07M -185.74M -164.7M -155.22M
Depreciation & Amortization
10.35M 10.14M 9.41M 8.98M 8.32M 7.68M 7.1M 8.55M 7.87M 6.64M 6.27M 6.07M 5.79M 6M 5.37M 2.82M 2.28M 1.7M
Stock-Based Compensation
43.52M 44M 43.92M 42.76M 41.83M 40.74M 39.41M 39.17M 36.53M 33.65M 31.01M 28.35M 27.66M 27.61M 29.24M 28.27M 25.33M 22.51M
Other Working Capital
2.55M -1.85M -732K 21.53M 15.34M 16.35M 28.68M 194K 10.58M 8.58M -3.11M 5.5M 7.13M -10.32M -7.31M -6.74M -6.22M 5.58M
Other Non-Cash Items
-2.92M -2.95M -3.63M 5.1M -9.45M -9.69M -9.28M -21.22M -6.68M -2.59M 370K 8.12M 15.05M 13.56M 13.53M 35.56M 28.61M 29.07M
Deferred Income Tax
n/a n/a n/a -12.47M n/a n/a n/a 12.47M n/a n/a n/a 1.06M 1.8M 2.53M 3.15M 2.72M 2.22M 1.62M
Change in Working Capital
2.55M -1.85M -732K 21.53M 15.34M 16.35M 13.46M -7.9M 2.49M 3.04M 6.08M 2.73M 4.82M -13.93M -3.39M 13.03M 13.09M 23.65M
Operating Cash Flow
-203.8M -208.69M -209.78M -192.18M -197.22M -194.24M -194.92M -221.6M -208.31M -196.48M -178.14M -153.06M -136.62M -136.1M -121.16M -103.33M -93.17M -76.68M
Capital Expenditures
-2.31M -4.19M -5.86M -10.2M -13.27M -15.48M -16.47M -15.09M -10.94M -9.69M -8.62M -7.4M -10.73M -9.34M -7.71M -20.59M -20.68M -23.56M
Cash Acquisitions
n/a n/a n/a 81.23K 28.32K -7K n/a 42.64M 42.67M 42.71M 42.7M 71.03K 518K 843K 843K 102K -43K -88K
Purchase of Investments
-335.99M -321.87M -245.89M -330.34M -324.51M -358.83M -390.92M -381.29M -402.23M -472.36M -519.35M -339.87M -373.35M -285.08M -245.88M -303.73M -311.48M -289.68M
Sales Maturities Of Investments
353.07M 364.7M 383.45M 369.31M 335.88M 348.01M 309.33M 287.8M 279.81M 253.25M 272.89M 260.37M 255.53M 279.46M 272.44M 271.85M 233.68M 159.97M
Other Investing Acitivies
n/a n/a n/a -81.23K -28.32K 7K n/a -67.07K -96.02K 142.89M 142.84M 142.89M 142.44M -904.04K -871.85K -130.85K 14.15K 59.15K
Investing Cash Flow
14.77M 38.64M 131.71M 28.77M -1.89M -26.31M -98.07M -65.85M -90.64M -43.05M -69.33M 56.12M 14.47M -14.97M 18.85M -52.47M -98.48M -153.26M
Debt Repayment
-7K 9K 24K 110K 121K 92K 65K 35K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a -47K -47K -47K -47K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
19K 32K 32K -54K -65K -65K -58K 603K 638K 638K 631K 1.14M 1.14M 1.14M 1.14M 2.55M 2.48M 1.8M
Financial Cash Flow
183.25M 184.6M 185.79M 3.34M 192.65M 191.27M 208.4M 316.45M 156.49M 173.56M 155.29M 46.85M 17.35M 104.89K 37.68K 282.48M 282.96M 283.11M
Net Cash Flow
-5.79M 14.53M 107.73M -160.06M -6.46M -29.27M -84.58M 29.01M -142.45M -65.98M -92.18M -48.95M -77.05M -122.11M -64.63M 163.18M 101.21M 61.96M
Free Cash Flow
-206.11M -212.88M -215.64M -202.38M -210.49M -209.72M -211.39M -236.69M -219.25M -206.16M -186.76M -160.46M -147.35M -145.44M -128.88M -123.92M -113.85M -100.24M